...
首页> 外文期刊>Phytotherapy research: PTR >Phytotherapy of Benign Prostatic Hyperplasia. A Minireview
【24h】

Phytotherapy of Benign Prostatic Hyperplasia. A Minireview

机译:良性前列腺增生的植物疗法。迷你评论

获取原文
获取原文并翻译 | 示例
           

摘要

Benign prostate hyperplasia (BPH) is a common condition affecting older men, with an incidence that is agedependent. Histological BPH, which typically develops after the age of 40 years, ranges in prevalence from >50% at 60 years to as high as 90% by 85 years of age. Typical symptoms include increased frequency of urination, nocturia, urgency, hesitancy, and weak urine stream. Conventional medicines used for the treatment of BPH include alpha blockers and 5-alpha reductase inhibitors. This articles review the mode of action, the efficacy, and the safety, including herb-drug interactions of the most common botanicals (Serenoa repens, Pygeum africanum, Urtica dioica, and Cucurbita pepo) and nutraceuticals (isoflavones, lycopene, selenium, and β-Sitosterol) in controlling the lower urinary tract symptoms associated to BPH.
机译:良性前列腺增生(BPH)是影响老年男性的常见病,其发病率与年龄有关。组织学BPH通常在40岁以后发展,其患病率从60岁时的> 50%到85岁时的高达90%不等。典型症状包括排尿次数增加,夜尿症,尿急,犹豫和尿流不畅。用于治疗BPH的常规药物包括α受体阻滞剂和5-α还原酶抑制剂。本文概述了作用方式,功效和安全性,包括最常见的植物药(Serenoa repens,非洲臀果木,非洲荨麻,荨麻二烯和西葫芦)和药材(异黄酮,番茄红素,硒和β)的药药相互作用-谷固醇)在控制与BPH相关的下尿路症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号